Managing potential adverse events during treatment with enfortumab vedotin + pembrolizumab in patients with advanced urothelial cancer

在晚期尿路上皮癌患者接受恩福妥单抗联合帕博利珠单抗治疗期间，如何管理潜在的不良事件